InvestorsObserver
×
News Home

Is KemPharm Inc (KMPH) Stock at the Top of the Biotechnology Industry?

Tuesday, July 06, 2021 01:29 PM | InvestorsObserver Analysts

Mentioned in this article

Is KemPharm Inc (KMPH) Stock at the Top of the Biotechnology Industry?

A rating of 93 puts KemPharm Inc (KMPH) near the top of the Biotechnology industry according to InvestorsObserver. KemPharm Inc's score of 93 means it scores higher than 93% of stocks in the industry. KemPharm Inc also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 105 out of the 148 industries.

Overall Score - 61
KMPH has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on KMPH!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With KemPharm Inc Stock Today?

KemPharm Inc (KMPH) stock is trading at $12.61 as of 1:26 PM on Tuesday, Jul 6, a drop of -$0.34, or -2.63% from the previous closing price of $12.95. The stock has traded between $11.92 and $12.83 so far today. Volume today is low. So far 573,111 shares have traded compared to average volume of 1,081,199 shares.

Click Here to get the full Stock Score Report on KemPharm Inc (KMPH) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App